Targetable gene fusions and aberrations in genitourinary oncology
Gene fusions result from either structural chromosomal rearrangement or aberrations
caused by splicing or transcriptional readthrough. The precise and distinctive presence of …
caused by splicing or transcriptional readthrough. The precise and distinctive presence of …
Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review
MNE Almeeri, M Awies, C Constantinou - Current Oncology Reports, 2024 - Springer
Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative
Review | Current Oncology Reports Skip to main content Springer Nature Link Account Menu …
Review | Current Oncology Reports Skip to main content Springer Nature Link Account Menu …
[HTML][HTML] The important role of poly adp-ribose polymerase inhibitor in prostate cancer
JY Joung, SH Kim - The Korean Journal of Urological Oncology, 2022 - new.kjuo.or.kr
Poly (ADP-ribose) polymerase inhibitors (PARP inhibitor) is a new targeted drug for
metastatic prostate cancer in which the patient has a mutation on homologous repair gene …
metastatic prostate cancer in which the patient has a mutation on homologous repair gene …
[PDF][PDF] 전립선암치료에서의Poly ADP-Ribose Polymerase 억제재의역할과중요성
정재영， 김성한 - 대한비뇨기종양학회지, 2022 - e-juo.org
Poly (ADP-ribose) polymerase inhibitors (PARP inhibitor) is a new targeted drug for
metastatic prostate cancer in which the patient has a mutation on homologous repair gene …
metastatic prostate cancer in which the patient has a mutation on homologous repair gene …